Edgestream Partners L.P. bought a new position in shares of Neogen Corporation (NASDAQ:NEOG – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 149,639 shares of the company’s stock, valued at approximately $1,915,000. Edgestream Partners L.P. owned 0.07% of Neogen as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors also recently made changes to their positions in NEOG. Canton Hathaway LLC bought a new position in Neogen in the 3rd quarter worth about $26,000. Parallel Advisors LLC lifted its holdings in Neogen by 121.8% in the third quarter. Parallel Advisors LLC now owns 2,085 shares of the company’s stock worth $27,000 after purchasing an additional 1,145 shares during the period. Farther Finance Advisors LLC lifted its holdings in Neogen by 76.1% in the third quarter. Farther Finance Advisors LLC now owns 2,184 shares of the company’s stock worth $28,000 after purchasing an additional 944 shares during the period. Nykredit A S bought a new position in Neogen in the 2nd quarter valued at about $28,000. Finally, Public Employees Retirement System of Ohio bought a new stake in shares of Neogen during the 2nd quarter worth about $34,000. 96.73% of the stock is owned by institutional investors.
Neogen Trading Down 2.8%
Neogen stock opened at $10.55 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.92 and a current ratio of 3.90. The business’s 50-day simple moving average is $12.14 and its 200-day simple moving average is $10.54. The firm has a market capitalization of $2.30 billion, a PE ratio of -42.20, a PEG ratio of 3.77 and a beta of 1.86. Neogen Corporation has a 52 week low of $5.37 and a 52 week high of $14.26.
Analysts Set New Price Targets
NEOG has been the subject of several research analyst reports. Guggenheim restated a “buy” rating and issued a $14.00 price objective (up from $12.00) on shares of Neogen in a report on Wednesday, September 30th. Weiss Ratings reissued a “sell (d-)” rating on shares of Neogen in a research note on Wednesday, November 4th. Wall Street Zen upgraded Neogen from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 14th. Finally, Piper Sandler raised shares of Neogen from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $13.00 to $14.00 in a research note on Wednesday, August 26th. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $12.67.
Check Out Our Latest Stock Report on NEOG
Neogen Profile
Neogen Corporation develops and markets products and services focused on food and animal safety. Its offerings help food producers, processors, laboratories and livestock producers detect risks, support animal health and meet safety and quality requirements. Neogen’s food safety products include tests for foodborne pathogens, allergens, toxins and sanitation indicators, as well as related laboratory supplies and services. Its animal safety offerings include veterinary instruments, animal health products, biosecurity solutions and genetic testing services for livestock.
Recommended Stories
- Five stocks we like better than Neogen
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.
